Polyneuropathy clinical trials

Explore recruiting polyneuropathy clinical trials.

Recruiting polyneuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Polyneuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 Two-Part (Open-label, Single Ascending Dose (Part 1) and Open-label, Single Dose Expansion (Part 2)) Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN).

France, Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effect of intravenous immunoglobulins on painful sensory neuropathy evaluated by aggregated N-of-one trials

Norway

Phase II and Phase III (Integrated) EU CTIS Study details

Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy

Austria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

(LAX) A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - A strategy trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

TRITON-PN: A Phase 3, Global, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (hATTR-PN)

France, Italy, Greece, Spain, Sweden, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants with Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sweden, Spain, Norway, Germany, Denmark, Poland +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Polyneuropathy trials by city

Polyneuropathy in Toronto Polyneuropathy in Vancouver Polyneuropathy in Montreal Polyneuropathy in Calgary Polyneuropathy in Edmonton Polyneuropathy in Ottawa Polyneuropathy in Winnipeg Polyneuropathy in Quebec City Polyneuropathy in Hamilton Polyneuropathy in Kitchener Polyneuropathy in London Polyneuropathy in Halifax Polyneuropathy in New York Polyneuropathy in Los Angeles Polyneuropathy in Chicago Polyneuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease